David Marcinek, Ph.D., featured in Endpoints News article

David Marcinek, Ph.D., was recently featured in an EndPoints News article titled, “Exclusive: ARCH-backed exercise-in-a-pill startup quietly laid off half its staff, ‘fully pivoted’ in October.”

Dr. Marcinek, a professor of radiology and director of the Translational Bioenergetics Lab, commented on studies about mitochondria, which he’s familiar with — he was recently the lead author on a paper that suggests an oral supplement, urolithin A, may help improve muscle endurance and mitochondrial health in humans.

Endpoints News is a news organization reporting and analyzing the top global biotech and pharmaceutical research and development news of the day.

Read the full article on the Endpoints News website.